Polymeric drugs derived from ibuprofen with improved antiinflammatory profile

Journal of Biomedical Materials Research

Volumn 32, Issue 4, 1996, Pages 553-560

  Liso, P A ^a   Rebuelta, M ^a   San Roman J ^b   Gallardo, A ^b   Villar, A M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b INSTITUTO DE CIENCIA Y TECNOLOGÍA DE POLÍMEROS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCOMPATIBILITY; COMPOSITION EFFECTS; DERIVATIVES; LIVING SYSTEMS STUDIES; MACROMOLECULES; PHARMACOKINETICS; PHYSIOLOGICAL MODELS; POLYMERS;

IBUPROFEN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POLYMERIC DRUGS; POLYMETHACRYLIC MACROMOLECULAR DERIVATIVES;

DRUG PRODUCTS;

IBUPROFEN; METHACRYLIC ACID DERIVATIVE; POLYMETHACRYLIC ACID DERIVATIVE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANALYSIS; DRUG CLEARANCE; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; DRUG HYDROLYSIS; DRUG METABOLISM; DRUG RELEASE; HYPERALGESIA; INFLAMMATION; KIDNEY METABOLISM; MOUSE; NONHUMAN;

ANALGESICS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; CARRAGEENAN; DELAYED-ACTION PREPARATIONS; DRUG IMPLANTS; FREUND'S ADJUVANT; HYDROLYSIS; HYPERALGESIA; IBUPROFEN; METHACRYLATES; MICE; SUSPENSIONS;

EID: 0030561157     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(199612)32:4<553::AID-JBM8>3.0.CO;2-Q     Document Type: Article

References (36)

1. G. Thomas and M. D. Kantor, "Diagnosis and treatment: drugs five years later. Ibuprofen," Ann. Intern. Med., 91, 877-882 (1979).
2. L. J. Davis, "Drug evaluation data: Ibuprofen," Drug Intell. Clin. Pharm., 9, 501-503 (1975).
3. R. F. N. Mills, S. S. Adams, E. F. Clife, W. Dickinson, and J. S. Nicholson, "The metabolism of Ibuprofen," Xenobiotica, 3, 589 (1973).
4. A. J. Hutt and J. Caldwell, "The metabolic chiral inversion of 2-arylpropionic acids. A novel route with pharmacological consequences," J. Pharm. Pharmacol., 35, 693-704 (1983).
5. M. R. Wright, N. M. Davies, and F. Jamali, "Rationale for development of stereochemically pure enantiomers: are the R-enantiomers of chiral nonsteroidal anti-inflammatory drugs inactive?" J. Pharm. Sci., 83, 911-912 (1994).
6. H. Nozu, "Ibuprofen: Highly potent inhibitor of prostaglandin," Biophys. Acta, 529, 493 (1978).
7. J. R. Vane, J. A. Mitchell, I. Appleton, A. Tomlinson, D. Bishop-Bailey, J. Croxtall, and D. A. Willoughby, "Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation," Proc. Natl. Acad. Sci. USA, 91, 2046-2050 (1994).
8. J. A. Mitchell, P. Akarasereenont, C. Thiemermann, R. J. Flower, and J. R. Vane, "Selectivity of nonsteroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase," Proc. Natl. Acad. Sci. USA, 90, 11693-11697 (1993).
9. J. L. Masferrer, M. S. Zwwifel, P. T. Manning, S. D. Hauser, K.M. Leahy, W. G. Smith, P.C. Isakson, and K. Seibert, "Selective inhibition of inducible cylooxygenase 2 in vivo is anti-inflammatory and non-ulcerogenic," Proc. Natl. Acad. Sci. USA, 91, 3228-3232 (1994).
10. P. V. Kulkarni, S. B. Rajur, P. P. Antich, T. M. Aminabhavi, and M. I. Aralaguppi, "Transport studies on macromolecules used as drug carriers," J. Macromol. Sci. Rev. Macromol. Chem. Phys., C30, 441-490 (1990).
11. L. G. Donamura and O. Vogl, Polymeric Drugs, Academic Press, New York, 1978, p. 124.
12. R. Duncan and J. Kopecek, "Soluble synthetic polymers as potential drug carriers," Adv. Polym. Sci., 57, 51-101 (1984).
13. N. L. Krinick, Y. Sun, D. Joyner, J. D. Spikes, R. C. Straight, and J. Kopecek, "A polymeric drug delivery system for the simultaneous delivery of drugs activable by enzymes and for light," J. Biomater. Sci. Polym. Ed., 5, 303-324 (1994).
14. J. San Roman, V. Darias, J. Bravo, C. Sanchez-Mateo, M. L. Tello, S. S. Abdellah, and J. M. Vivas, "Preliminary pharmacological study of polymeric acrylic derivatives of salicylic and paracetamol," Pharmazie, 47, 1-3 (1992).
15. P. Sinko and J. Kohn, "Polymeric drug delivery systems, an overview," ACS Symp. Ser., 520, 18-41 (1993).
16. A. Gallardo and J. San Roman, "Synthesis and characterization of a new poly(methacrylamide) bearing side groups of biomedical interest," Polymer, 34, 394-400 (1993).
17. A. Gallardo, Polímeros Acrílicos Biocompatibles con Actividad Farmacológica, Ph. D. thesis, Facultad CC.QQ. (UCM), Madrid, 1993, pp. 163-170.
18. P. A. Liso, Derivados Metacrílicos de Ibuprofen: Actividad AINE y Comportamiento Farmacocinético, Predoctoral thesis, Facultad Farmacia (UCM), Madrid, 1994, pp. 49-96.
19. L. O. Randall and J. J. Sellito, "A method for measurement of analgesic activity on inflammed tissue," Arch. Int. Pharmacodyn., 111, 409-419 (1957).
20. E. I. Takesue, W. Schaffer, and W. Jukniewicz, "Modification of the Randall-Selitto analgesic apparatus,"J. Pharm. Pharmacol., 21, 877-882 (1969).
21. R. J. Tallarida and R. B. Murray, Manual of Pharmacological Calculations with Computer Programs, 2nd ed., Springer-Verlag, New York, 1987.
22. C. A. Winter, E. A. Risley, and G. W. Nuss, "Carrageenan-induced edema in hind paw of the rat as an assay for anti-inflammatory drugs," Proc. Soc. Exp. Biol. Med., 111, 544-547 (1962).
23. N. S. Doherty and B. V. Robinson, "The inflammatory response to carrageenan," J. Pharm. Pharmacol., 27, 701-703 (1975).
24. Y. Mizhusima, W. Tsukada, and T. Akimoto, "A modification of the ajuvant arthritis for testing anti-rheumatic drugs," J. Pharm. Pharmacol., 14, 781-785 (1972).
25. E. Sugishita, S. Amagaya, and Y. Ogihara, "Antiinflammatory testing methods: comparative evaluation of mice and rats," J. Pharm. Dyn., 4, 565-575 (1981).
26. J. E. Pettersen, G. A. Ulsaker, and E. Jellum, "Studies on the metabolism of 2,4-isobutylphenylpropionic acid (Ibuprofen) by gas chromatography and mass spectrometry," J. Chromatog., 145, 143-146 (1978).
27. M. R. Wright, S. Sattari, D. R. Brocks, and F. Jamali, "Improved HPLC assay method for the enantiomers of Ibuprofen," J. Chromatog., 583, 259-265 (1992).
28. H. Ringsdorf, "Structure and properties of pharmacologically active polymers," J. Polym. Sci. Symp., 51, 135-153 (1975).
29. A. Gallardo and J. San Roman, "Kinetic behavior of methacrylic monomers with large polar side substituents in free radical polymerization," Macromolecules, 25, 5836-5840 (1992).
30. J. San Roman, A. Gallardo, and B. Levenfeld, "New polymers for biomedical applications: synthesis and characterization of acrylic systems with pharmacological activity," Macromol. Symp., 84, 145-158 (1994).
31. P. A. Liso, M. Rebuelta, A. M. Villar, A. Gallardo, and J. San Roman, "Antinociceptive and antipyretic properties of a new conjugated Ibuprofen methacrylic polymeric controlled delivery system," J. Control. Release, 33, 429-436 (1995).
32. P. A. Liso, M. Rebuelta, A. M. Villar, A. Gallardo, J. San Roman, and V. Darias, "Ibuprofen polimérico: avances en la terapia de la inflamación," Rev. Farmacol. Clin. Exp., Special issue, 228 (1993).
33. E. J. C. Franssen, F. Moolenaar, D. De Zeeuw, and D. K. F. Meijer, ́Low molecular weight proteins as carriers for renal drug-targeting: Naproxen coupled to lysozyme via the spacer L-lactic acid,́ Pharm. Res., 10, 963-969 (1993).
34. A. Hussarn, J. Truelove, and H. Kostendander, "Kinetics and mechanism of hydrolysis of 1-(2′-acetoxibenzoil)-2-deoxy-D-glucopyranose, a novel aspirin prodrug," J. Pharm. Sci., 68, 299-301 (1979).
35. J. Honorato-Perez, D. Fos, C. Alamo, F. Martin, J. R. Suarez, and B. Montes-Jovellar, "Pharmacokinetics of Ibuprofen following oral administration of single-dose Lobuprofen in healthy volunteers," Rev. Farmacol. Clin. Exp., 6, 89-95 (1989).
36. S. S. Adams, P. Bresloff, and C. G. Mason, "Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-) isomer," J. Pharm. Pharmacol., 28, 256-257 (1976).